Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 22;25(1):143.
doi: 10.1186/s12882-024-03575-1.

Clinical characteristics and outcomes of maintenance hemodialysis patients with COVID-19 during the Omicron wave of the pandemic in Beijing: a single center retrospective study

Yujing Pan  1 , Dan Li  2 , Zhoucang Zhang  1 , Jing Xu  1 , Xinping Sun  3 , Mei Wang  1 , Jiaxiang Ding  4
Affiliations

Clinical characteristics and outcomes of maintenance hemodialysis patients with COVID-19 during the Omicron wave of the pandemic in Beijing: a single center retrospective study

Yujing Pan et al. BMC Nephrol. .

Abstract

Background: The clinical manifestations and prognosis of hemodialysis patients with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) during the Omicron wave of the pandemic infection were still unclear. This study investigated the clinical characteristics of patients undergoing maintenance hemodialysis (MHD) infected with it.

Methods: This retrospective single-center study included 151 patients undergoing MHD. Healthcare workers were selected as control group were assessed from December 1, 2022 to March 31, 2023. Clinical data, laboratory test results, treatment protocols, and prognoses were collected and analyzed.

Results: The study population included 146 patients with MHD, 93 (63.7%) of whom were infected with SARS-CoV-2. The number of non-severe, severe, and critical cases was 84 (90.3%), 4 (4.3%), and 5 (5.3%), respectively. Six patients (6.5%) died during the study period. The main symptoms of SARS-CoV-2 infection, including fever, cough, and fatigue, were less common in patients with MHD than the controls. During SARS-CoV-2 infection, the C-reactive protein (2.9 vs. 11.8 mg/dl, p < 0.0001) and ferritin levels(257.7 vs. 537 ng/l, p < 0.0001) were elevated. The hemoglobin(113vs 111 g/L, p = 0.0001) and albumin levels(39.4 vs. 36.1 g/L, p < 0.0001) decreased. Generally, it took two months for the hemoglobin levels to recover. Positivity rate for SARS-COV-2 serum immunoglobin G (IgG) antibodies and IgG titers were lower in dialysis patients than the controls. Age was positively associated with disease severity, while age and hyponatremia were associated with death.

Conclusions: Patients with MHD and COVID-19 were primarily classified as non-severe. SARS-CoV-2 infection would soon lead to the increase of inflammation related acute response protein in dialysis patients, and then lead to the decrease of hemoglobin and albumin. About 9.6% in HD patients were severe cases and had poor prognosis. Advanced age and hyponatremia were associated with disease severity and prognosis.

Keywords: Coronavirus disease 2019 (COVID-19); Maintenance hemodialysis (MHD); Omicron variant; Prognosis; Severe acute respiratory syndrome coronavirus-2 (SARS-cov-2).

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Diagnosis flow chart
Fig. 2
Fig. 2
Common signs and symptoms of MHD patients and controls with COVID-19
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Angeletti A, Zappulo F, Donadei C, Cappuccilli M, Di Certo G, Conte D, Comai G, Donati G. La Manna G: Immunological effects of a single hemodialysis treatment. Med (Kaunas) 2020, 56(2). - PMC - PubMed
    1. Hsu CM, Weiner DE, Aweh G, Miskulin DC, Manley HJ, Stewart C, Ladik V, Hosford J, Lacson EC, Johnson DS, et al. COVID-19 among US Dialysis patients: risk factors and outcomes from a National Dialysis Provider. Am J Kidney Dis. 2021;77(5):748–e756741. doi: 10.1053/j.ajkd.2021.01.003. - DOI - PMC - PubMed
    1. Fisher M, Yunes M, Mokrzycki, Golestaneh L, Alahiri E, Coco M. Chronic hemodialysis patients hospitalized with COVID-19: short-term outcomes in the Bronx, New York. Kidney360. 2020;1(8):755–62. doi: 10.34067/KID.0003672020. - DOI - PMC - PubMed
    1. Chen CY, Shao SC, Chen YT, Hsu CK, Hsu HJ, Lee CC, Sun CY, Chen YC, Hung MJ, Wu IW. Incidence and clinical impacts of COVID-19 infection in patients with hemodialysis: systematic review and Meta-analysis of 396,062 hemodialysis patients. Healthc (Basel) 2021, 9(1). - PMC - PubMed
    1. Wang S, Niu P, Su Q, He X, Tang J, Wang J, Feng Y, Chen C, Zhao X, Chen Z, et al. Genomic surveillance for SARS-CoV-2 - China, September 26, 2022 to January 29, 2023. China CDC Wkly. 2023;5(7):143–51. doi: 10.46234/ccdcw2023.026. - DOI - PMC - PubMed

Publication types

Substances